IRadimed Corporation (IRMD) Balance Sheet
IRMD balance sheet, 2025
December 31, 2025 · U.S. dollars$108.8M assets = $14.2M liabilities + $94.6M equity
Both columns are drawn to the same scale: what IRMD owns equals what it owes plus shareholders’ equity. Hover a block for its value.
IRMD financial health
Descriptive bands, not a rating. Fiscal 2025.
IRMD balance sheet trends, 2016–2025
| Metric | Trend | Then | Latest | Change |
|---|---|---|---|---|
| Total assets | $37.2M2016 | $108.8M2025 | +12.7%/yr | |
| Total liabilities | $5.3M2016 | $14.2M2025 | +11.5%/yr | |
| Shareholders’ equity | $31.9M2016 | $94.6M2025 | +12.8%/yr | |
| Cash & short-term investments | $25.7M2016 | $51.2M2025 | +8.0%/yr | |
| Total debt | $1.4M2016 | $154,6882024 | −24.0%/yr | |
| Net cash (debt) | $24.3M2016 | $52.1M2024 | +$27.8M | |
| Working capital | $30.5M2016 | $71.0M2025 | +$40.5M | |
| Book value per share | $2.662016 | $7.362025 | +12.0%/yr | |
| Current ratio | 9.332016 | 7.982025 | −1.35 | |
| Debt / equity | 0.042016 | 0.002024 | −0.04 | |
| Shares outstanding | 12.0M2016 | 12.9M2025 | +0.8%/yr |
Change is the average annual growth (CAGR) or the difference between the first and latest year.
IRMD assets
IRMD liabilities and equity
IRMD debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease obligations.
IRMD balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash & short-term investments | $51.2M | $52.2M | $49.8M | $58.0M | $62.5M | $52.0M | $46.3M | $34.4M | $26.3M | $25.7M |
| Cash & equivalents | $51.2M | $52.2M | $49.8M | $58.0M | $62.0M | $50.1M | $43.5M | $28.0M | $18.2M | $17.7M |
| Short-term investments | — | — | — | $0 | $501,855 | $1.9M | $2.8M | $6.3M | $8.1M | $8.0M |
| Receivables | $13.7M | $10.6M | $12.2M | $13.3M | $5.1M | $4.6M | $7.3M | $4.2M | $3.8M | $3.8M |
| Inventory | $11.6M | $10.4M | $12.8M | $5.4M | $4.3M | $3.9M | $3.6M | $4.1M | $4.2M | $3.9M |
| Other current assets | $4.8M | $2.0M | $1.2M | $885,053 | $4.3M | $3.2M | $1.8M | $1.9M | $776,736 | $826,591 |
| Total current assets | $81.2M | $75.2M | $76.0M | $77.5M | $76.2M | $63.7M | $59.0M | $44.5M | $35.1M | $34.2M |
| Property, plant & equipment (net) | $23.9M | $17.0M | $11.3M | $4.6M | $4.6M | $4.8M | $5.0M | $1.9M | $1.9M | $1.5M |
| Goodwill & intangible assets | $3.4M | $3.1M | $2.5M | $2.1M | $1.1M | $960,885 | $860,087 | $832,519 | $885,502 | $918,712 |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $333,000 | $3.0M | $2.3M | $1.3M | $966,421 | $1.5M | $1.9M | $1.2M | $1.2M | $651,351 |
| Total assets | $108.8M | $98.3M | $92.2M | $85.5M | $82.9M | $71.1M | $66.7M | $48.4M | $39.0M | $37.2M |
| Liabilities | ||||||||||
| Accounts payable | $1.8M | $1.9M | $1.9M | $1.8M | $782,903 | $657,054 | $993,742 | $772,470 | $656,723 | $1.1M |
| Short-term debt | — | $153,264 | $427,963 | $293,466 | $276,568 | $255,698 | $240,843 | $133,000 | $1.7M | $1.4M |
| Deferred revenue | $2.9M | $2.3M | $2.6M | $3.4M | $2.6M | $1.9M | $1.7M | $1.8M | $1.6M | $1.0M |
| Total current liabilities | $10.2M | $8.5M | $16.3M | $8.6M | $6.8M | $4.9M | $5.9M | $4.7M | $4.1M | $3.7M |
| Long-term debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Lease obligations | $0 | $154,688 | $2.0M | $2.2M | $2.5M | $2.7M | $3.0M | — | — | — |
| Other long-term liabilities | $4.0M | $3.0M | $4.4M | $3.3M | $3.9M | $4.8M | $5.3M | $1.8M | $2.0M | $1.6M |
| Total liabilities | $14.2M | $11.5M | $20.7M | $11.8M | $10.7M | $9.7M | $11.2M | $6.5M | $6.1M | $5.3M |
| Shareholders' equity | ||||||||||
| Common stock & paid-in capital | $1,000 | $1,271 | $1,265 | $1,259 | $1,254 | $1,231 | $1,177 | $1,099 | $1,060 | $1,072 |
| Retained earnings (deficit) | $64.2M | $56.8M | $43.3M | $47.3M | $47.0M | $37.7M | $36.3M | $26.7M | $20.4M | $19.9M |
| Treasury stock | — | — | — | — | — | — | — | — | $0 | $0 |
| Accumulated other comprehensive income | — | — | — | — | $17,012 | $37,087 | $30,374 | −$42,192 | −$48,909 | −$36,849 |
| Minority interest | — | — | — | — | — | — | — | — | $0 | $0 |
| Total shareholders' equity | $94.6M | $86.8M | $71.4M | $73.7M | $72.2M | $61.4M | $55.5M | $41.9M | $32.9M | $31.9M |
| Key figures | ||||||||||
| Total debt | — | $154,688 | $2.0M | $2.2M | $2.5M | $2.7M | $3.0M | $133,000 | $1.7M | $1.4M |
| Net cash (debt) | — | $52.1M | $47.7M | $55.8M | $60.0M | $49.3M | $43.3M | $34.2M | $24.6M | $24.3M |
| Working capital | $71.0M | $66.7M | $59.7M | $68.9M | $69.4M | $58.8M | $53.1M | $39.9M | $31.0M | $30.5M |
| Tangible book value | $91.2M | $83.7M | $68.9M | $71.6M | $71.1M | $60.4M | $54.7M | $41.1M | $32.0M | $31.0M |
| Book value per share | $7.36 | $6.79 | $5.61 | $5.83 | $5.73 | $4.93 | $4.52 | $3.46 | $2.81 | $2.66 |
| Shares outstanding | 12.9M | 12.8M | 12.7M | 12.6M | 12.6M | 12.4M | 12.3M | 12.1M | 11.7M | 12.0M |
| Current ratio | 7.98 | 8.84 | 4.65 | 9.06 | 11.18 | 12.96 | 10.06 | 9.50 | 8.61 | 9.33 |
| Quick ratio | 6.37 | 7.38 | 3.80 | 8.33 | 9.91 | 11.50 | 9.14 | 8.23 | 7.39 | 8.04 |
| Debt / equity | — | 0.00 | 0.03 | 0.03 | 0.03 | 0.04 | 0.05 | 0.00 | 0.05 | 0.04 |
| Equity / assets | 87.0% | 88.3% | 77.5% | 86.2% | 87.1% | 86.4% | 83.2% | 86.6% | 84.4% | 85.7% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & short-term investments | $59.1M | $56.4M | $51.2M | $56.5M | $53.0M | $50.3M | $52.2M | $51.7M | $48.5M | $45.1M | $49.8M | $46.7M |
| Cash & equivalents | $59.1M | $56.4M | $51.2M | $56.5M | $53.0M | $50.3M | $52.2M | $51.7M | $48.5M | $45.1M | $49.8M | $46.7M |
| Receivables | $13.2M | $13.4M | $13.7M | $13.9M | $10.9M | $12.7M | $10.6M | $10.4M | $12.0M | $13.0M | $12.2M | $12.8M |
| Inventory | $12.3M | $11.9M | $11.6M | $11.7M | $11.2M | $10.6M | $10.4M | $11.3M | $12.1M | $12.7M | $12.8M | $11.7M |
| Other current assets | $2.2M | $4.8M | $4.8M | $2.8M | $2.3M | $1.5M | $2.0M | $948,841 | $1.0M | $1.0M | $1.2M | $735,124 |
| Total current assets | $86.7M | $86.4M | $81.2M | $84.9M | $77.4M | $75.1M | $75.2M | $74.3M | $73.6M | $71.9M | $76.0M | $71.9M |
| Property, plant & equipment (net) | $24.2M | $24.2M | $23.9M | $23.8M | $22.9M | $20.4M | $17.0M | $14.4M | $10.8M | $11.4M | $11.3M | $11.0M |
| Goodwill & intangible assets | $3.4M | $3.3M | $3.4M | $3.4M | $3.4M | $3.3M | $3.1M | $2.9M | $2.7M | $2.7M | $2.5M | $2.5M |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $607,000 | $456,000 | $333,000 | $2.6M | $2.8M | $2.9M | $3.0M | $2.6M | $2.8M | $2.1M | $2.3M | $2.0M |
| Total assets | $115.0M | $114.4M | $108.8M | $114.7M | $106.4M | $101.7M | $98.3M | $94.2M | $89.9M | $88.0M | $92.2M | $87.4M |
| Liabilities | ||||||||||||
| Accounts payable | $1.8M | $2.2M | $1.8M | $2.3M | $1.9M | $2.6M | $1.9M | $1.4M | $1.1M | $1.3M | $1.9M | $2.8M |
| Short-term debt | — | — | — | — | — | $59,221 | $153,264 | $261,244 | $367,618 | $418,814 | $427,963 | $421,379 |
| Deferred revenue | $3.5M | $3.4M | $2.9M | $3.2M | $3.3M | $2.6M | $2.3M | $2.6M | $2.5M | $2.3M | $2.6M | $1.9M |
| Total current liabilities | $9.2M | $12.1M | $10.2M | $12.8M | $8.8M | $8.5M | $8.5M | $8.1M | $7.5M | $7.6M | $16.3M | $7.9M |
| Long-term debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Lease obligations | — | — | $0 | $0 | $0 | $59,221 | $154,688 | $264,075 | $371,849 | $1.9M | $2.0M | $2.1M |
| Other long-term liabilities | $4.1M | $3.8M | $4.0M | $3.6M | $3.3M | $3.2M | $3.0M | $2.8M | $2.8M | $4.3M | $4.4M | $5.0M |
| Total liabilities | $13.2M | $15.9M | $14.2M | $16.4M | $12.1M | $11.7M | $11.5M | $10.8M | $10.3M | $11.9M | $20.7M | $12.8M |
| Shareholders' equity | ||||||||||||
| Common stock & paid-in capital | $1,000 | $1,000 | $1,000 | $1,272 | $1,272 | $1,272 | $1,271 | $1,267 | $1,267 | $1,266 | $1,265 | $1,260 |
| Retained earnings (deficit) | $70.2M | $67.5M | $64.2M | $66.3M | $62.9M | $59.3M | $56.8M | $53.5M | $50.4M | $47.4M | $43.3M | $46.7M |
| Accumulated other comprehensive income | — | — | — | — | — | — | — | — | — | $0 | — | $0 |
| Total shareholders' equity | $101.7M | $98.5M | $94.6M | $98.4M | $94.3M | $90.1M | $86.8M | $83.4M | $79.7M | $76.1M | $71.4M | $74.6M |
| Key figures | ||||||||||||
| Total debt | — | — | — | — | — | $59,221 | $154,688 | $264,075 | $371,849 | $1.9M | $2.0M | $2.1M |
| Net cash (debt) | — | — | — | — | — | $50.3M | $52.1M | $51.5M | $48.2M | $43.2M | $47.7M | $44.6M |
| Working capital | $77.6M | $74.3M | $71.0M | $72.1M | $68.6M | $66.7M | $66.7M | $66.2M | $66.1M | $64.3M | $59.7M | $64.0M |
| Tangible book value | $98.3M | $95.2M | $91.2M | $95.0M | $90.9M | $86.8M | $83.7M | $80.5M | $76.9M | $73.5M | $68.9M | $72.1M |
| Book value per share | $7.90 | $7.65 | $7.35 | $7.65 | $7.35 | $7.02 | $6.79 | $6.53 | $6.24 | $5.97 | $5.61 | $5.85 |
| Shares outstanding | 12.9M | 12.9M | 12.9M | 12.9M | 12.8M | 12.8M | 12.8M | 12.8M | 12.8M | 12.7M | 12.7M | 12.7M |
| Current ratio | 9.46 | 7.13 | 7.98 | 6.64 | 8.78 | 8.87 | 8.84 | 9.21 | 9.87 | 9.44 | 4.65 | 9.13 |
| Quick ratio | 7.89 | 5.76 | 6.37 | 5.50 | 7.25 | 7.44 | 7.38 | 7.70 | 8.11 | 7.64 | 3.80 | 7.55 |
| Debt / equity | — | — | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.03 | 0.03 | 0.03 |
| Equity / assets | 88.5% | 86.1% | 87.0% | 85.7% | 88.6% | 88.5% | 88.3% | 88.5% | 88.6% | 86.5% | 77.5% | 85.3% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed March 6, 2026); data from EODHD.
IRMD financial position
At the end of fiscal 2025 (December 31, 2025), IRadimed had total assets of $108.8 million (up 10.6% from a year earlier), total liabilities of $14.2 million and shareholders' equity of $94.6 million. Its current ratio was 7.98. In the latest quarter (ended June 30, 2026) total assets were $115.0 million and equity $101.7 million.
Related: IRMD income statement, IRMD cash flow statement, IRMD key metrics. See the IRMD stock overview for the latest quote and news.
IRMD balance sheet FAQ
What are IRadimed's total assets?
IRadimed reported total assets of $108.8 million at the end of fiscal 2025 (December 31, 2025), compared with $98.3 million a year earlier.
How much cash does IRadimed have?
IRadimed held $51.2 million in cash and short-term investments at the end of fiscal 2025.
What is IRadimed's book value?
IRadimed's shareholders' equity (book value) was $94.6 million at the end of fiscal 2025, or $7.36 per share.
What is IRadimed's current ratio?
IRadimed had current assets of $81.2 million and current liabilities of $10.2 million, a current ratio of 7.98 (it can cover its short-term obligations).
How much goodwill does IRadimed have?
IRadimed carried $3.4 million of goodwill and intangible assets, 3.1% of total assets, at the end of fiscal 2025.